GB1205687A - Creación de Inventos y Patentes con Inteligencia Artificial

GB1205687A – Aminoalkanol esters and their pharmaceutically acceptable acid-addition salts, and production thereof
– Google Patents

GB1205687A – Aminoalkanol esters and their pharmaceutically acceptable acid-addition salts, and production thereof
– Google Patents
Aminoalkanol esters and their pharmaceutically acceptable acid-addition salts, and production thereof

Info

Publication number
GB1205687A

GB1205687A
GB48040/68A
GB4804068A
GB1205687A
GB 1205687 A
GB1205687 A
GB 1205687A
GB 48040/68 A
GB48040/68 A
GB 48040/68A
GB 4804068 A
GB4804068 A
GB 4804068A
GB 1205687 A
GB1205687 A
GB 1205687A
Authority
GB
United Kingdom
Prior art keywords
group
hydrogen atom
prepared
formula
compound
Prior art date
1967-10-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB48040/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Dainippon Pharmaceutical Co Ltd

Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1967-10-13
Filing date
1968-10-10
Publication date
1970-09-16

1968-10-10
Application filed by Dainippon Pharmaceutical Co Ltd
filed
Critical
Dainippon Pharmaceutical Co Ltd

1970-09-16
Publication of GB1205687A
publication
Critical
patent/GB1205687A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS

C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton

C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton

C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated

C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/13—Amines

A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members

C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals

C07D213/81—Amides; Imides

C07D213/82—Amides; Imides in position 3

Abstract

1,205,687. Phenylalkylaminoalkanols and esters thereof. DAINIPPON PHARMACEUTICAL CO. Ltd. 10 Oct., 1968 [13 Oct., 1967(2)], No. 48040/68. Heading C2C. Novel compounds of formula and pharmaceutically acceptable acid addition salts thereof in which formula R is a hydrogen atom or a phenyl group, R1 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R11 is an acyl group or a hydrogen atom, the group A is an ethylene group or a methylmethylene group provided that A is not a methylmethylene group when R is a hydrogen atom, and n is a positive integer of 3 or 2, are prepared by (i) condensing a compound of the general formula with a compound of formula Z-(CH 2 ) n -OR11, A1 is a methylenecarbonyl, an ethylene or a methylmethylene group, R, R11 and n are as hereinbefore defined, and Y and Z are different and are a halogen atom or a group wherein R1 is as hereinbefore defined, (ii) reducing the product of (i) when A1 is a methylenecarbonyl group, (iii) reacting the product, of the last procedure carried out, with an acylating agent when R11 is a hydrogen atom and if desired, (iv) reacting the product of the last procedure carried out, with an alkylating agent when R1 is a hydrogen atom and if desired. 3,3-Diphenylpropyl chloride is prepared by action of thionyl chloride on 3,3-dipropan-l-ol. 2 – (3,3 – Diphenylpropionylamino)- ethanol is prepared by reaction of 2-aminoethanol with 3,3-diphenylpropionyl chloride prepared in situ by action of thionyl chloride on the acid. Pharmaceutical compositions in conventional forms for oral or parenteral administration comprise an above novel compound wherein R11 is an acyl group or salt and a carrier therefor and the novel compound or composition is used in treatment of cardiovascular disease.

GB48040/68A
1967-10-13
1968-10-10
Aminoalkanol esters and their pharmaceutically acceptable acid-addition salts, and production thereof

Expired

GB1205687A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

JP6589767

1967-10-13

JP6589667

1967-10-13

Publications (1)

Publication Number
Publication Date

GB1205687A
true

GB1205687A
(en)

1970-09-16

Family
ID=26407064
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB48040/68A
Expired

GB1205687A
(en)

1967-10-13
1968-10-10
Aminoalkanol esters and their pharmaceutically acceptable acid-addition salts, and production thereof

Country Status (8)

Country
Link

US
(1)

US3700680A
(en)

BE
(1)

BE722246A
(en)

CH
(3)

CH549552A
(en)

DE
(2)

DE1817740A1
(en)

FR
(1)

FR8461M
(en)

GB
(1)

GB1205687A
(en)

NL
(1)

NL6814688A
(en)

SE
(2)

SE368195B
(en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

FR2077916A1
(en)

1970-02-24
1971-11-05
Dainippon Pharmaceutical Co
Amino-alkanols as antidepressants

US4649204A
(en)

1983-05-23
1987-03-10
Mcneilab, Inc.
Dialkanolamine derivatives

US20040254146A1
(en)

2002-05-21
2004-12-16
Nastech Pharmaceutical Company Inc.
Carboxylate salts of galantamine and their pharmaceutical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US2766252A
(en)

1955-01-24
1956-10-09
Endo Lab
Esters of nicotinic acid

GB1175516A
(en)

1966-04-15
1969-12-23
Science Union & Cie
New Phenyl-Aminopropane Derivatives and Preparations Containing them

1968

1968-10-09
US
US766297A
patent/US3700680A/en
not_active
Expired – Lifetime

1968-10-10
SE
SE02421/70A
patent/SE368195B/xx
unknown

1968-10-10
GB
GB48040/68A
patent/GB1205687A/en
not_active
Expired

1968-10-10
SE
SE13674/68A
patent/SE365792B/xx
unknown

1968-10-11
DE
DE19681817740
patent/DE1817740A1/en
active
Granted

1968-10-11
BE
BE722246D
patent/BE722246A/xx
unknown

1968-10-11
DE
DE1802656A
patent/DE1802656B2/en
active
Granted

1968-10-11
FR
FR169665A
patent/FR8461M/fr
not_active
Expired

1968-10-14
CH
CH50371A
patent/CH549552A/en
not_active
IP Right Cessation

1968-10-14
CH
CH1532968A
patent/CH525179A/en
not_active
IP Right Cessation

1968-10-14
NL
NL6814688A
patent/NL6814688A/xx
unknown

1968-10-14
CH
CH50471A
patent/CH521308A/en
not_active
IP Right Cessation

Also Published As

Publication number
Publication date

FR8461M
(en)

1972-01-07

CH525179A
(en)

1972-07-15

SE368195B
(en)

1974-06-24

DE1802656A1
(en)

1969-05-22

CH549552A
(en)

1974-05-31

DE1802656C3
(en)

1975-02-13

DE1817740C3
(en)

1974-09-05

SE365792B
(en)

1974-04-01

DE1817740B2
(en)

1974-02-07

DE1802656B2
(en)

1974-07-04

BE722246A
(en)

1969-04-11

NL6814688A
(en)

1969-04-15

CH521308A
(en)

1972-04-15

DE1817740A1
(en)

1970-09-17

US3700680A
(en)

1972-10-24

Información de contacto